Description: This research report examines the ban of the use of genetic testing information in life insurance mortality.

Description: Investigate from many angles the variety of potential impacts of increasing inflation on actuarial products and services in the insurance and retirement industries.

Description: The Committee on Life Insurance Mortality and Underwriting Surveys of the Society of Actuaries Research Institute sent companies a survey in May of 2019 on mortality improvement practices. Note this survey was completed prior to the onset of COVID-19, so that issue was not addressed in this survey. The purpose of the survey was to examine mortality improvement practices with respect to life insurance and annuity pricing and financial projections in both the U.S. and Canada.

Description: Businesses across the board have been drastically impacted by the effects of COVID-19 over the course of 2020, and insurance was not immune. Perhaps most relevant to this industry’s current capital and liquidity concern is the prevailing low interest rate environment. This has been a global trend in the last decade, and treasury rates in much of the developed world are at or near zero. Reduced investment returns limit an insurer’s ability to achieve their desired return on equity, eliminating previously profitable strategies that depended on the leverage of life and annuity balance sheets. Focus and activity have instead shifted to other methods to counteract the low interest rate markets and accompanying capital strain. Examples include increased mergers and acquisitions (M&A) activity within the insurance industry and an increasing focus by private equity firms in the insurance market for asset-intensive products, both of which reflect the goal of increasing yield rates on capital.

Description: After years of discussion and debate, PrinciplesBased Reserving (PBR) is finally a reality. Small insurance companies have a unique opportunity to decide between electing for the company-wide exemption or adopting the PBR methods. This article discusses the benefits and challenges of the options available to small insurers under VM-20 as well as best practices that have been found along the way.

Description: In the third quarter of 2022, publicly traded life insurers reported on their financial and operational activities, which included a downturn in income from alternative investments, the continuing impact of COVID, the impact of equity market returns on variable annuity products, and growth trends related to pension risk transfer transactions.

Description: Initiated by the Product Development Section, this report examines global product development (PD) practices of life insurance and annuity companies.

Description: An overview of how the VM-31 requirements for documenting PBR approaches and assumptions can/should reflect the Actuarial Standard of Practice on Modeling, ASOP No. 56

Description: The Emerging Issues in Underwriting Survey was intended for direct life writing insurance companies in the US and Canada. The Survey looked at various trends that could have a significant impact on the process and practices of life insurance underwriting in the future.

Description: Over the past month, the evolution of the COVID-19 pandemic has raised questions on how this outbreak will impact life insurance industry claims. This report pulls emerging U.S. COVID-19 hospitalization data and deaths obtained from the Centers for Disease Control and Prevention’s (CDC) COVIDView, a Weekly Surveillance Summary of U.S. COVID-19 activity, and compares it to data from past U.S. influenza seasons obtained from the CDC’s Flu Activity and Surveillance webpage.